Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Titanium dioxide and bisoctrizole

EU orphan designation number: EU/3/05/262
Active ingredient: Titanium dioxide and bisoctrizole
Indication: Treatment of UV-A and visible light-induced photosensitivity disorders (chronic actinic dermatitis, cutaneous porphyrias, actinic prurigo and solar urticaria)
Sponsor: Orfagen
CRDPF Langlade, 3 avenue Hubert Curien, BP 13562, F-31035 Toulouse CEDEX 1, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2005 Centralised Orphan - Designation EMEA/OD/068/04 (2005)570 of 03/03/2005
30/05/2011 Other procedure EMEA/OD/068/04
12/07/2013 Centralised Orphan - Removal of orphan designation from Community Register